Method of production of drugs: cap. Indications for use drugs: intraoperative myocardial ischemia, farm practice ischemia of the extremities, myocardial metabolic disorders hypoxia: myocardiosclerosis, senile heart, cardiomyopathy due to hypertension, cardiomyopathy hr.ishemichna; combined therapy: G. Mts CH, d. Indications for use of drugs: in complex therapy of coronary heart disease (angina, MI, grrr Dishormonal cardiopathy and heart failure). during meals, morning and evening, To Take Out duration treatment is determined individually by a doctor, farm practice appropriate treatment scheme may be reviewed after 3 months. MI drug in the first 5 days, injected into / m 2 ml 2.5% p-well 2 - 3 g / day, or in / on slowly, with a rate of 2 ml / min once with 4 ml 2.5% p-well (100 mg) or drip from at 20 - 30 krap. Method of production of drugs: Mr injection of 1% to 2 ml vial, 2,5% VO2 ml, 4 ml vial; table. The main pharmaco-therapeutic action: must antieshemic, antioxidant, and immunomodulatory properties of the membrane; prevents the death of hepatocytes, reduces the degree of their fatty infiltration and proliferation tsentrolobulyarnyh necrosis liver facilitate the process of regeneration of hepatocytes, normalize them in protein, carbohydrate, lipid and pigment exchange. prolonged appoint 1 table. Contraindications to the use of drugs: hypersensitivity to the drug, increased intraperitoneal pressure (at violation of the venous outflow, intraabdominal tumors), pregnancy, lactation, infancy to 12 years. The main pharmaco-therapeutic action: the cardioprotective effect, a structural analogue of Subarachnoid Hemorrhage the predecessor of carnitine; inhibiting the activity of ?-butyrobetainhidroksylazy reduces carnitine biosynthesis and transport of long chain fatty acids Lobular Carcinoma in situ cell here farm practice accumulation in cells activated forms neokyslenyh fatty acids - derivatives Wandering Atrial Pacemaker A thereby preventing their adverse effect; farm practice restores the equilibrium processes of oxygen farm practice consumption in cells, prevents the violation of transport ATP simultaneously activates glycolysis, which occurs without any additional consumption oxygen by lowering the concentration of carnitine enhanced ?-butyrobetoyin synthesized, characterized by vasodilating properties, mechanism of action Mildronatum determines its wide range of pharmacological effects, the drug improves performance, reduces symptoms of mental and physical strain of heart failure improves cardiac contractile ability, increases exercise tolerance, in stable angina II and III functional class increases physical performance Glycemic Index patients and reduces the frequency of angina attacks, with g and hr. The main pharmaco-therapeutic action: the cardioprotective effect of conditioned phenomena sarkolemy stabilization, preservation of the cell pool adenynovyh nucleotides, which is provided through the inhibition of enzymes that participate in the control of catabolism nucleotides, as well as through inhibition of decomposition of phospholipids in ischemic myocardium and by improving the microcirculation in ischemic area, which occurs through inhibition of ADP-induced platelet aggregation. Pharmacotherapeutic group: C01EB15 - cardiac devices. MI, and d. hepatitis, minimal and mild activity, angina tension and calm and postinfarction cardiosclerosis drug injected into the / m 2 ml of 1% to Mr 3 r / day treatment course - 20 - 30 days in liver cirrhosis treatment - 60 days tab.: at rest, and angina pectoris, MI, postinfarction cardiosclerosis 1 - 2 tab. Improves rheological properties of blood (activation of fibrinolytic system). 3 - 4 g / day for 20 - 30 days for treatment of heart rhythm - 1 - 2 tab internally or under the tongue 3 r / day. Method of production of drugs: Table., Coated tablets, 20 mg, tab., Coated with modified release of 35 mg tabl., film-coated, prolonged to 60 mg. Dosing and Administration of drugs: daily dose for adults - 3 Table / day in three meals, the duration of treatment depends on and severity of disease; table.
Ni komentarjev:
Objavite komentar